Current Trends in Pharmacy and Pharmaceutical Chemistry

Online ISSN: 2582-5062

Current Trends in Pharmacy and Pharmaceutical Chemistry is the official Journal of Ateos Foundation of Science Education and Research, hosted and Managed IP Innovative Publications Pvt. Ltd, New Delhi, India. Current Trends in Pharmacy and Pharmaceutical Chemistry is an open access, peer-reviewed quarterly international journal publishing since 2019 and is published under auspices of the Ateos Foundation of Science Education and Research. It aims to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. more...

Article type

Review Article


Article page

34-40


Authors Details

Vijay Gaikwad*


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 295

PDF Downloaded: 147


Review of indole, A versatile pharmacophoric moiety


Review Article

Author Details : Vijay Gaikwad*

Volume : 6, Issue : 2, Year : 2024

Article Page : 34-40

https://doi.org/10.18231/j.ctppc.2024.011



Suggest article by email

Get Permission

Abstract

Indole is a heterocyclic compound, known for its alluring smell. Indole contributes to the rich aroma of various flowers such as jasmine and orange blossoms. Indole plays a vital role in numerous biological processes, including hormone regulation, neurotransmission, and immune response. Indole derivatives serve as a foundation for developing drugs in several therapeutic areas, such as antiviral, anticancer, and psychiatric medications.


Keywords: Indole, Medicine, Medicinal Chemistry, Pharmacology, Pharmacological Chemistry


How to cite : Gaikwad V, Review of indole, A versatile pharmacophoric moiety. Curr Trends Pharm Pharm Chem 2024;6(2):34-40

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.